Press Release EVE Energy Achieves World’s First 400MWh Energy Storage Project with 628Ah Ultra-Large Cells
Press Release Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
Press Release TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen
Press Release HUHUTECH International Group Inc. Announces First Half of Fiscal Year 2025 Financial Results
Press Release NIBS Assumes Management of the Sustainable Facilities Tool to Power the Future of Federal Building Innovation
